Skip to content
ClinicCompass
Losing Weight: treatment options
Find by concern

How do GLP-1 weight loss programs at med spas actually work?

Semaglutide and tirzepatide changed what non-surgical weight loss can do, with 15 to 20 percent body weight lost in trials. The medication is only part of it. What separates a good program from a bad one is the supervision, the dosing, and the plan for what happens when you stop.

Dr. Victoria Taraska Medically reviewed by Dr. Victoria Taraska, MD, FRCPC

For decades the honest answer to non-surgical weight loss was that nothing worked well for long. GLP-1 medications changed that. Semaglutide and tirzepatide produce 15 to 20 percent body weight loss in a year for most people who stay on them, a result that previously required surgery, and they are now offered by a large share of med spas and aesthetic clinics.

That availability is the good news and the problem. The medication is powerful. The program around it is what determines whether you lose weight safely, keep it off, and avoid the side effects that make people quit.

What the medication does

GLP-1 drugs mimic a gut hormone that signals fullness to the brain and slows stomach emptying. Appetite drops, portions shrink without effort, and the constant food noise many people describe goes quiet. Semaglutide acts on the GLP-1 pathway alone. Tirzepatide adds a second hormone pathway and produces somewhat greater weight loss in head-to-head data, often with fewer stomach side effects at a given dose, at a higher price. Both are weekly injections started low and increased over months.

What a real program includes

The dose schedule is where programs differ most. Titrating too fast is the main cause of nausea, and it is the main reason people stop. A good clinic starts low, increases only when tolerated, and adjusts to you rather than to a calendar. Beyond dosing, look for: intake bloodwork and a health history review by a prescriber, monthly check-ins, guidance on protein intake and strength training to protect muscle while losing fat, and a written plan for tapering off. Muscle loss is the quiet cost of rapid weight loss, and the programs that address it produce people who look and feel better at their new weight.

What happens after

The medication manages appetite while you take it. Stopping without habits in place returns the appetite, and much of the weight, within a year for most people. The programs worth paying for treat the medication as a window to build the eating and training patterns that hold the result, and they taper rather than stop cold. Ask about this at the first consultation. It is the question that separates a medical program from a subscription.

How to choose a provider

You want a prescriber you actually meet, a named pharmacy for any compounded medication, an all-in monthly price, and a clear answer about the off-ramp. Clinics that advertise the medication alone, with no labs and no visits, are cheaper for a reason.

Browse the clinics below. Bring your weight history and any medications you take; a serious program will ask for both before quoting.

Your options

Treatments for losing weight, compared

Best-first, with honest notes on when each is the right call.

Treatment Typical cost Downtime When it's the right call
Semaglutide (Wegovy / Ozempic) $250–$1,350 per month None. Nausea and fatigue are common during dose increases The medication behind Ozempic and Wegovy. Weekly injection, roughly 15 percent body weight lost over a year in trials. Widely available, well understood, the usual starting point.
Tirzepatide (Zepbound / Mounjaro) $300–$1,100 per month None. Nausea and GI side effects are common during dose increases The medication behind Mounjaro and Zepbound. Acts on two hormone pathways instead of one, with roughly 20 percent body weight lost in trials. Often better tolerated at equivalent doses. Typically costs more.
Medical Weight Loss (GLP-1) $250–$1,500 per month None. Mild nausea or fatigue possible in the first weeks of dose escalation The program around the medication: intake labs, a prescriber, dose titration, nutrition guidance, and monitoring. This is what you are actually paying a clinic for, and it is what a telehealth pill-mill leaves out.
Emsculpt NEO $750–$1,200 per session None. Slight muscle soreness possible Useful after weight loss for rebuilding muscle tone and definition, particularly on the abdomen. Not a weight loss treatment.
Skin Tightening $1,500–$4,500 per treatment area or full face/neck None. Possible mild swelling or tenderness For the loose skin that significant weight loss often leaves. Best started once weight is stable.
FAQ

Losing Weight: common questions

What does a GLP-1 program cost per month?

Compounded semaglutide programs at med spas commonly run a few hundred dollars per month including the medication and monitoring; tirzepatide runs higher. Brand-name Wegovy or Zepbound through a pharmacy costs more without insurance coverage, which is inconsistent for weight loss. Ask for the all-in monthly price including visits, labs, and the medication, and ask what changes as your dose increases.

Do you regain the weight after stopping?

Without a plan, most people regain a significant portion within a year, because the medication was managing appetite and stopping removes that. Programs that taper the dose, build nutrition and strength habits during treatment, and plan the transition do better. Ask any clinic what their off-ramp looks like before you start. If they do not have one, that is the answer.

Is compounded semaglutide safe?

Compounded versions from licensed pharmacies are widely used and generally well tolerated, but they are not FDA-approved products and quality varies by pharmacy. A good clinic tells you which pharmacy supplies their medication and why. Be cautious of prices far below the market, of programs with no prescriber visit, and of anything shipped without a prescription.

Sources

Where this information comes from

Clinical facts on this page are checked against these primary sources.

  1. 1.WEGOVY (semaglutide) injection, solution; WEGOVY (semaglutide) tablet - DailyMed, U.S. Food and Drug AdministrationSemaglutide is a GLP-1 receptor agonist that regulates appetite and delays gastric emptying, and dosing starts at 0.25 mg weekly with the dose escalated every 4 weeks to a maintenance level, backing the page's description of how GLP-1 drugs work (mimicking a fullness hormone and slowing stomach emptying) and its description of weekly injections started low and increased over months.
  2. 2.Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial, Nature Medicine, National Library of Medicine (PMC)The pivotal STEP 1 trial found a mean weight reduction of 14.9% at week 68 with semaglutide 2.4 mg, backing the page's 'roughly 15 percent body weight lost over a year in trials' figure for semaglutide.
  3. 3.ZEPBOUND- tirzepatide injection, solution - DailyMed, U.S. Food and Drug AdministrationTirzepatide is a dual GIP and GLP-1 receptor agonist that also delays gastric emptying, the SURMOUNT-1 trial found a 20.9% average body weight reduction at the 15 mg dose over 72 weeks, and dosing starts at 2.5 mg weekly with increases in 2.5 mg increments at least every 4 weeks, backing the page's description of tirzepatide acting on two hormone pathways, its roughly 20 percent trial result, and its weekly-injection titration schedule.
  4. 4.Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension, Diabetes, Obesity and Metabolism, National Library of Medicine (PMC)Participants who stopped semaglutide regained a mean of two-thirds of their prior weight loss during the one-year off-treatment extension, backing the page's statement that stopping the medication without habits in place returns much of the weight within a year for most people.
  5. 5.Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial, JAMA, National Library of Medicine (PMC)Patients switched from tirzepatide to placebo after a 20.9% mean weight loss at week 36 regained down to a net 9.9% loss by week 88, about half of what they had lost, while patients who continued treatment kept losing weight, backing the page's statement that stopping without a plan returns much of the weight and that programs which taper rather than stop cold do better.
Take the next step

Find Semaglutide (Wegovy / Ozempic) providers near you

Compare vetted clinics, real ratings, and local pricing in your city.

This page is for education, not medical advice or diagnosis. The right treatment depends on an in-person assessment by a qualified provider.